MSI2 and B-cell chronic lymphocytic leukemia: Our knockdown studies and in vitro and in vivo MSI2 functional blocking studies using a small molecule inhibitor (Ro 08-2750) that binds selectively to the RNA MSI2 binding site [44, 45] support the idea that MSI2 promotes CLL-cell survival.